Adar Poonawalla India Britain Brazil Sweden county Oxford city Oxford covid-19 vaccine patient Adar Poonawalla India Britain Brazil Sweden county Oxford city Oxford

Oxford COVID-19 vaccine: All you need to know about price, trial, production in India

Reading now: 846
www.livemint.com

Oxford's COVID-19 vaccine has shown a positive result in its initial trial. According to a report published in the British medical journal, The Lancet, the COVID-19 vaccine produced a dual immune response in people aged 18 to 55.Officially known as AZD1222, this COVID-19 vaccine candidate has been developed by the University of Oxford and British-Swedish pharmaceutial company AstraZeneca Plc.

The large-scale phase III human trials of Oxford COVID-19 vaccine has already started in Brazil.AstraZeneca has joined Serum Institute of India (SII), the world's largest vaccine manufacturers by number of doses produced and sold, to produce the potential vaccine.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA